Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 142-72-3
2. Magnesium Diacetate
3. Acetic Acid, Magnesium Salt
4. Magnesium Di(acetate)
5. Cromosan
6. Mg Acetate
7. Acetic Acid Magnesium Salt
8. Nu-mag
9. Acetic Acid, Magnesium Salt (2:1)
10. Mg(ii) Acetate
11. Magnesium Acetate Anhydrous
12. Magnesium Acetate, Mg(oac)2
13. 0e95jzy48k
14. Magnesium Acetate Solution
15. Chebi:62964
16. Magnesiumacetate
17. Nsc-75798
18. Cromosan; Magnesium Acetate, Mg(oac)2; Magnesium Diacetate
19. Ccris 7883
20. Einecs 205-554-9
21. Nsc 75798
22. Unii-0e95jzy48k
23. Magnesium;diacetate
24. Dsstox_cid_7097
25. Ec 205-554-9
26. Dsstox_rid_78308
27. Dsstox_gsid_27097
28. Schembl19919
29. Magnesium Acetate [ii]
30. Magnesium Acetate [mi]
31. Chembl1200691
32. Dtxsid7027097
33. Magnesium Acetate [inci]
34. Magnesium Acetate [who-dd]
35. Tox21_202557
36. Mfcd00003539
37. Akos015903568
38. Akos015903846
39. Db13996
40. Magnesium Acetate [orange Book]
41. Magnesium Acetate, 1m Aqueous Solution
42. Ncgc00260106-01
43. Cas-142-72-3
44. Ft-0774763
45. Q418767
46. Methyl4-(4-chlorophenyl)-2,4-dioxobutanoate
| Molecular Weight | 142.39 g/mol |
|---|---|
| Molecular Formula | C4H6MgO4 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 0 |
| Exact Mass | 142.0116504 g/mol |
| Monoisotopic Mass | 142.0116504 g/mol |
| Topological Polar Surface Area | 80.3 Ų |
| Heavy Atom Count | 9 |
| Formal Charge | 0 |
| Complexity | 25.5 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
ABOUT THIS PAGE
89
PharmaCompass offers a list of Magnesium Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Magnesium Acetate manufacturer or Magnesium Acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Magnesium Acetate manufacturer or Magnesium Acetate supplier.
PharmaCompass also assists you with knowing the Magnesium Acetate API Price utilized in the formulation of products. Magnesium Acetate API Price is not always fixed or binding as the Magnesium Acetate Price is obtained through a variety of data sources. The Magnesium Acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tox21_202557 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tox21_202557, including repackagers and relabelers. The FDA regulates Tox21_202557 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tox21_202557 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tox21_202557 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tox21_202557 supplier is an individual or a company that provides Tox21_202557 active pharmaceutical ingredient (API) or Tox21_202557 finished formulations upon request. The Tox21_202557 suppliers may include Tox21_202557 API manufacturers, exporters, distributors and traders.
click here to find a list of Tox21_202557 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Tox21_202557 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tox21_202557 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tox21_202557 GMP manufacturer or Tox21_202557 GMP API supplier for your needs.
A Tox21_202557 CoA (Certificate of Analysis) is a formal document that attests to Tox21_202557's compliance with Tox21_202557 specifications and serves as a tool for batch-level quality control.
Tox21_202557 CoA mostly includes findings from lab analyses of a specific batch. For each Tox21_202557 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tox21_202557 may be tested according to a variety of international standards, such as European Pharmacopoeia (Tox21_202557 EP), Tox21_202557 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tox21_202557 USP).
